Health experts say a new COVID vaccine is coming next month as a new variant called “Eris” is reportedly on the rise in the U.S.
Public health experts reportedly hope that Americans will welcome the new shot as they would a flu jab.
Critics say it’s unlikely that many Americans will agree to take the new drug. (Poll: Is the Country Going In The Right Direction Under Biden? VOTE)
New Covid vaccines are on the way as 'Eris' variant rises https://t.co/jCXvC4lyG8 pic.twitter.com/LagLCVlh21
— Reuters U.S. News (@ReutersUS) August 14, 2023
Surveys show the top reason for eschewing annual shots is that people believe they are protected from the virus because of previous shots or infections.
Pfizer, which is the largest maker of mRNA shots with BioNTech, has warned that they will offer fewer drugs if the new vaccine “does not do well.”
Moderna believes will be as low as 50 million shots. (Trending: Democrat Threatens To Leave Party In Scathing Statement)
Pharmacies such as CVS Health will reportedly help fight “declining concern about the virus, as well as fatigue and skepticism about the merits of this vaccine.”
COVID infections and hospitalizations are on the rise, and health officials are pointing to a new variant – EG.5, also nicknamed ‘Eris.’ What do we know about it, and should we be worried? https://t.co/TCAvC6kzb4 pic.twitter.com/IgrkMoerhb
— Reuters (@Reuters) August 14, 2023
Ashley Kirzinger, who serves as the Kaiser Family Foundation Director of Survey Methodology, said, “Public health officials, if they want to see a majority of adults get these annual vaccines, they’re going to have to make the case to the American public that COVID isn’t over and it still poses a risk to them.” (Poll: Do You Trust the Biden Family? VOTE)
Pfizer and Moderna have sold a whooping $56 billion worldwide in vaccine sales. However, this is dropping to an estimated $20 billion in 2023.